Alector (ALEC) Reports Q4 Loss, Beats Revenue Estimates

分组1 - Alector reported a quarterly loss of $0.34 per share, better than the Zacks Consensus Estimate of a loss of $0.39, representing an earnings surprise of +13.71% [1] - The company posted revenues of $6.24 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 103.43%, compared to $54.24 million in the same quarter last year [2] - Alector has surpassed consensus EPS estimates four times over the last four quarters and topped consensus revenue estimates three times [2] 分组2 - Alector shares have increased by approximately 40.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.7% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.41 on $3 million in revenues, and for the current fiscal year, it is -$1.19 on $12 million in revenues [7] - The Medical - Biomedical and Genetics industry, to which Alector belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook [8]